anmelden
FTSE All-Share
5.539,85
PKT
+30,20
PKT
+0,55
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.04.23 | GSK Buy | Deutsche Bank AG | |
| 03.04.23 | Unilever Underweight | JP Morgan Chase & Co. | |
| 03.04.23 | Diageo Neutral | UBS AG | |
| 03.04.23 | Glencore Outperform | RBC Capital Markets | |
| 03.04.23 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 03.04.23 | BP Hold | Jefferies & Company Inc. | |
| 03.04.23 | Diageo Underperform | RBC Capital Markets | |
| 31.03.23 | HSBC Outperform | RBC Capital Markets | |
| 31.03.23 | HSBC Neutral | Credit Suisse Group | |
| 30.03.23 | BP Buy | Deutsche Bank AG | |
| 30.03.23 | Shell (ex Royal Dutch Shell) Buy | Deutsche Bank AG | |
| 30.03.23 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.03.23 | Diageo Underperform | RBC Capital Markets | |
| 28.03.23 | Diageo Buy | Jefferies & Company Inc. | |
| 28.03.23 | Diageo Overweight | JP Morgan Chase & Co. | |
| 27.03.23 | Barclays Overweight | JP Morgan Chase & Co. | |
| 27.03.23 | Diageo Overweight | JP Morgan Chase & Co. | |
| 24.03.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 24.03.23 | Vodafone Group Buy | Deutsche Bank AG | |
| 24.03.23 | BAT Buy | Jefferies & Company Inc. | |
| 23.03.23 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 22.03.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 22.03.23 | Rio Tinto Underweight | JP Morgan Chase & Co. | |
| 21.03.23 | Prudential Overweight | JP Morgan Chase & Co. | |
| 21.03.23 | Vodafone Group Buy | Deutsche Bank AG | |
| 20.03.23 | Glencore Buy | UBS AG | |
| 17.03.23 | GSK Buy | Deutsche Bank AG | |
| 17.03.23 | London Stock Exchange (LSE) Buy | UBS AG | |
| 15.03.23 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.03.23 | HSBC Buy | UBS AG | |
| 14.03.23 | GSK Hold | Deutsche Bank AG | |
| 14.03.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 13.03.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 13.03.23 | BAT Neutral | JP Morgan Chase & Co. | |
| 10.03.23 | HSBC Outperform | RBC Capital Markets | |
| 10.03.23 | BP Buy | UBS AG | |
| 10.03.23 | AstraZeneca Neutral | UBS AG | |
| 10.03.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 09.03.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.03.23 | BP Neutral | JP Morgan Chase & Co. |